Dr. Gregory Fontana, M.D.
Claim this profileLos Robles Regional Medical Center
Studies Von Willebrand Disease
Studies Aortic Valve Stenosis
9 reported clinical trials
14 drugs studied
Affiliated Hospitals
Clinical Trials Gregory Fontana, M.D. is currently running
Transcatheter Valve Repair
for Mitral Regurgitation
This trial tests a new device called Edwards PASCAL that fixes leaky heart valves without surgery. It is for patients who can't have surgery or haven't improved with other treatments. The device helps the valve close better, stopping blood from leaking backward.
Recruiting1 award N/A9 criteria
Tendyne Transcatheter Mitral Valve System
for Mitral Regurgitation
Prospective, controlled, multicenter clinical investigation with four trial cohorts: Randomized, Non-repairable, Severe Mitral Annular Calcification (MAC) and Severe Mitral Annular Calcification Continued Access Protocol (MAC CAP). Subjects in the Randomized cohort will be randomized in a 1:1 ratio to the trial device or to the MitraClip system. Subjects in the Non-repairable, Severe MAC, and Severe MAC CAP cohorts will receive the trial device. The objective of the Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation (SUMMIT) is to evaluate the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System for the treatment of patients with symptomatic, moderate-to-severe or severe mitral regurgitation or for patients with symptomatic mitral valve disease due to severe mitral annular calcification. This randomized controlled trial will provide the opportunity to evaluate the safety and clinical benefits of the Tendyne Transcatheter Mitral Valve System compared to the MitraClip System in patients with symptomatic, moderate-to-severe or severe mitral regurgitation, within approved MitraClip indications. In addition, the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System will be evaluated in patients with severe mitral annular calcification who are at prohibitive risk for mitral valve surgery. Patients who are not suitable for mitral valve surgery for reasons other than severe mitral annular calcification and are also not suitable for transcatheter repair with MitraClip, will be enrolled in the Non-repairable cohort. Subjects will be seen at screening, pre- and post-procedure, discharge, 30 days, 3 months, 6 months, and annually through 5 years.
Recruiting1 award N/A4 criteria
More about Gregory Fontana, M.D.
Clinical Trial Related7 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Gregory Fontana, M.D. has experience with
- Portico Re-sheathable Transcatheter Aortic Valve System
- Portico™ NG Valve And FlexNav™ Delivery System
- Portico™ NG (Navitor) Valve And FlexNav™ Delivery System
- Navitor Titan Valve (35mm) Valve And Large FlexNav™ Delivery System
- Tendyne Mitral Valve System
- MitraClip System
Breakdown of trials Gregory Fontana, M.D. has run
Von Willebrand Disease
Aortic Valve Stenosis
Valvular Heart Disease
Mitral Regurgitation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gregory Fontana, M.D. specialize in?
Gregory Fontana, M.D. focuses on Von Willebrand Disease and Aortic Valve Stenosis. In particular, much of their work with Von Willebrand Disease has involved treating patients, or patients who are undergoing treatment.
Is Gregory Fontana, M.D. currently recruiting for clinical trials?
Yes, Gregory Fontana, M.D. is currently recruiting for 2 clinical trials in Thousand Oaks California. If you're interested in participating, you should apply.
Are there any treatments that Gregory Fontana, M.D. has studied deeply?
Yes, Gregory Fontana, M.D. has studied treatments such as Portico Re-sheathable Transcatheter Aortic Valve System, Portico™ NG Valve and FlexNav™ Delivery System, Portico™ NG (Navitor) Valve and FlexNav™ Delivery System.
What is the best way to schedule an appointment with Gregory Fontana, M.D.?
Apply for one of the trials that Gregory Fontana, M.D. is conducting.
What is the office address of Gregory Fontana, M.D.?
The office of Gregory Fontana, M.D. is located at: Los Robles Regional Medical Center, Thousand Oaks, California 91360 United States. This is the address for their practice at the Los Robles Regional Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.